Refine by
Microbiome Equipment & Supplies In Qatar
110 equipment items found
Manufactured by:Ardigen based inKraków, POLAND
We solve your problems by combining our expertise into the Ardigen Microbiome Translational ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Our first-in-class keystone single-strain biotherapies address the root causes of the disease by regenerating a healthy microbiome, with subsequent deep beneficial effect on ...
Manufactured by:Notitia Biotechnologies based inMonmouth Junction, NEW JERSEY (USA)
NM108 is an investigational botanical drug that is designed to treat diseases by promoting the growth of either the existing or replenished Foundation Guild™ bacteria in a patient's gut microbiome. NM108 is currently in phase 2 trial as well as available for Expanded Access (compassionate ...
Manufactured by:Adiso Therapeutics based inConcord, MASSACHUSETTS (USA)
ADS024 is an oral single strain live biotherapeutic product (SS-LBP). A naturally occurring live biotherapeutic product, ADS024 possesses a dual mechanism of action. It is bactericidal toward Clostridioides difficile and degrades Toxins A and B produced by C. difficile while maintaining other components of the microbiome. ADS024 is a single strain multimodal LBP and is manufactured from a ...
by:Osel Inc. based inMountain View, CALIFORNIA (USA)
Most viruses enter the body via mucosal surfaces. The natural microbiota at these sites, may neutralize some viral particles before infection of the host can occur. Using a proprietary technology, MucoCept harnesses the human microbiome and enhances it to further virus neutralization. In the current MucoCept platform technology, we have modified a commensal Lactobacillus to express a potent ...
Manufactured by:MedBiome Inc. based inOttawa, ONTARIO (CANADA)
The RapidAIM technology allows the rapid screening of compounds against individual human microbiomes and greatly accelerates the discovery of compounds that target the human microbiomes. Our current technology can also be used to de-risk compounds, stratify patients based on their microbiome responses and other ...
Manufactured by:EnteroBiotix Ltd based inGlasgow, UNITED KINGDOM
Intestinal microbiota transfer (IMT) involves the transfer of microbiome communities from a healthy person into the intestinal tract of another person suffering from a microbiome mediated ...
Manufactured by:DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc. based inOttawa, ONTARIO (CANADA)
DNA Genotek has created millions of custom-branded sample collection kits. Rely on their experienced design team to portray the look and feel you want for your human genomic or microbiome project or service, while satisfying even the most complex operational requirements. Customization options include uniquely designed collection device packaging (secondary outer box), co-branding of device label ...
Manufactured by:Finch Therapeutics Group, Inc. based inSomerville, MASSACHUSETTS (USA)
FIN-211 is an orally administered, Enriched Consortia product candidate designed to address both the gastrointestinal (GI) and behavioral symptoms of ASD. ASD is a behaviorally defined condition characterized by difficulties with interpersonal interaction, communication, and repetitive or restrictive patterns of behavior and activities. A subset of individuals with ASD experience significant GI ...
Manufactured by:Locus Biosciences, Inc. based inMorrisville, NORTH CAROLINA (USA)
Locus has built the most innovative tool to reach into the human body and deliver a therapeutic manufactured by the ...
Manufactured by:Notitia Biotechnologies based inMonmouth Junction, NEW JERSEY (USA)
BM306 is an investigational live biotherapeutic product that contains the Foundation Guild™ bacteria in a defined consortium. This investigational drug is designed to treat diseases by replenishing the missing or extinct Foundation Guild™ bacteria in a patient's gut ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso4 is an exploratory program targeting the gut-brain axis for the treatment of mood disorders. Over the last 5 years, there has been increasing evidence that the gut microbiome was associated with neurological and behavioral disorders, which led to the so called “gut-brain axis” ...
Manufactured by:DermBiont, Inc. based inBoston, MASSACHUSETTS (USA)
We are focused on developing therapies that treat diseases of the skin at their root cause and fulfill the unmet needs of patients living with skin conditions. Our unique insights into the skin microbiome enable our discovery and clinical efforts. ...
Manufactured by:OptiBiotix Health Plc. based inHeslington, UNITED KINGDOM
LPGOS is a galactooligosaccharide (GOS) produced by the OptiBiotix LPLDL® strain (LPGOS®). OptiBiotix believes this creates opportunities to use LPGOS in a wide range of food products and applications to help reduce cardiovascular risk factors and improve health. ...
by:BacVax, Inc. based inPhoenix, ARIZONA (USA)
Antibiotics are currently the main defense against bacterial infections, but every treatment with antibiotics has unintended consequences. First, antibiotic-resistant mutants of the bacteria targeted by treatment may be selected. Second, the by-stander bacteria, for example in the GI tract, are also exposed to antibiotics and may become resistant. Third, the microbiome is significantly disturbed ...
Manufactured by:EnteroBiotix Ltd based inGlasgow, UNITED KINGDOM
Both inside and out, the human body harbours ecosystems of micro-organisms, including bacteria, viruses, fungi and archaea. These microorganisms, their genomic potential and their collective repertoire of activity are known as ‘the ...
Manufactured by:MV BioTherapeutics SA based inBellinzona, SWITZERLAND
SNP-apyrase for oral use in the treatment of IBD • Lead compound, MV010, has shown animal PoC in a murine model of ulcerative colitis. • Abrogation of the pro-inflammatory function of extracellular ATP in the intestine without systemic immune suppression. • Amplification of secretory IgA production in Peyer's patches and gut-associated lymphoid tissue (GALT), ensuring high specificity for ...
Manufactured by:Enterome based inParis, FRANCE
EO2401 is an innovative, off-the-shelf immunotherapy discovered by ...
Manufactured by:NuBiyota based inNew York, NEW YORK (USA)
NuBiyota’s Microbial Ecosystem Therapeutics (MET) technology utilizes the microbiota derived from an individual “super donor”. This microbiota demonstrated efficacy across several different indications in the form of FMT ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso1 is a clinical stage development program aiming at harnessing the potential of Christensenella minuta as a groundbreaking biotherapy to treating obesity and metabolic disorders. The goal of our disruptive approach is to return to obese patients christensenella, which have the unique ability to repair the unbalanced microbiome, thereby restoring impaired key ...